We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Brand drug manufacturers increased wholesale prices for drugs most commonly used by Americans 50 and older at more than twice the rate of inflation from April 2004 to March 2005, according to an AARP report.
Drugmakers must target their direct-to-consumer (DTC) advertisements at age-appropriate audiences, and firms no longer will be able to run reminder ads that mention a drug’s name but not its indication, according to PhRMA’s new guiding principles on DTC drug promotions.
Roughly 600,000 patients have connected to prescription drug assistance programs under a recently launched PhRMA-led initiative that aims to help low-income Americans afford their medications.
Drugmakers need to take a more active role in developing and promoting federal healthcare IT projects — specifically those related to electronic prescribing systems (“eprescribing”), according to members of a PhRMA committee.
PhRMA has launched a new online clearinghouse that it calls the first website to collect and archive reports, articles, warning letters and policy papers on drug importation.
The pharmaceutical industry is ratcheting up its concerns over the FDA’s plan to communicate emerging drug-safety information before it has been fully vetted.
The use of electronic technologies to authenticate prescription drugs should focus initially on the dispensing sites of medicines, according to a new PhRMA proposal to secure the supply chain.
There are currently 399 cancer treatments in development, representing new uses for existing medicines and potential breakthrough treatments, according to a survey commissioned by PhRMA.